1 recruiting, 1 terminated. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Recruiting 1, Terminated 1 |
Follow Spectrum Analysis: new trials by email Literature Review of Spectrum Analysis trials Research Report on Spectrum Analysis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Oral Bevacizumab-800CW and Cetuximab-800CW Administration to Detect Early Esophageal Adenocarcinomas Avastin, Erbitux, Fluorescence endoscopy and multi-diameter single fiber reflectance/single fiber fluorescence (MDSFR/SFF) spectroscopy - Barrett's Esophagus Without Dysplasia, Barrett Oesophagitis With Dysplasia | Phase 2 | Recruiting | University Medical Center Groningen | 25 | 2023-09-15 | 2026-04-13 |
| Photodynamic Therapy in Treating Patients With Resectable Non-Small Cell Lung Cancer That Has Spread to the Pleura chemotherapy, porfimer sodium, immunohistochemistry staining method - Lung Cancer, Metastatic Cancer | Phase 2 | Terminated | Abramson Cancer Center at Penn Medicine | 9 | 2004-11-01 | 2020-11-24 |
Adenocarcinoma Of Esophagus (1) · Barrett Esophagus (1) · Carcinoma, Non-Small-Cell Lung (1) · Lung Neoplasms (1) · Neoplasm Metastasis (1) · Pleural Effusion, Malignant (1)
Abramson Cancer Center at Penn Medicine (1) · University Medical Center Groningen (1)
Netherlands (1) · United States (1)
Keith Cengel, MD, PhD (1) · Wouter B. Nagengast, Prof. dr. (1)